NantHealth, Inc
NH was delisted on the 23rd of May, 2023.
45 hedge funds and large institutions have $18.8M invested in NantHealth, Inc in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 9 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
5% less capital invested
Capital invested by funds: $19.7M → $18.8M (-$900K)
8% less funds holding
Funds holding: 49 → 45 (-4)
37% less call options, than puts
Call options by funds: $500K | Put options by funds: $797K
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$468K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$418K |
| 3 |
Squarepoint
New York
|
+$287K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$121K |
| 5 |
BlackRock
New York
|
+$120K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$917K |
| 2 |
Morgan Stanley
New York
|
-$546K |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$326K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$173K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$137K |
NH Hedge Fund Activity: Q1 2021 in Review
45 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in NantHealth, Inc (NH) for Q1 2021, worth a combined $18.8M — down 4.6% from $19.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of NH and 5 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 19 added.
The largest buyer was JP Morgan Chase, adding an estimated $468K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $917K sold.
- 45 institutional investors held NantHealth, Inc (NH) as of Q1 2021, down from 49 in Q4 2020.
- Funds reported $18.8M of NantHealth, Inc stock for Q1 2021, down 4.6% quarter-over-quarter.
- 5 funds opened new NantHealth, Inc positions in Q1 2021 and 9 closed out, a net change of -4 holders.
- The largest NantHealth, Inc buyer in Q1 2021 was JP Morgan Chase, an estimated $468K added.
- The largest NantHealth, Inc seller in Q1 2021 was Renaissance Technologies, an estimated $917K sold.
Based on aggregated 13F filings for Q1 2021.